Shares of Intellia Therapeutics (NASDAQ:NTLA) were up over 10% on Monday, after Wolfe Research upgraded the company to ...

Wolf Research upgraded Walt Disney (DIS) shares to ‘Outperform’ from ‘Peer Perform’ on Monday, citing durable strengths in ...

Wolfe Research's Peter Supino downgraded the stock’s Tokyo-listed shares, which fell 10% on Monday amid Trump's tariffs.

Investing.com -- Wolfe Research upgraded U.S. Bancorp (BVMF:USBC34) to "Outperform," citing a attractive valuation and expected improvements in operating performance. USB has been the worst ...

As previously reported, Wolfe Research analyst Peter Supino downgraded Fox Corp. (FOXA) to Underperform from Peer Perform with a $48 price ...

Wolfe Research analyst Joshua Tilton upgraded Varonis (VRNS) to Outperform from Peer Perform with a $50 price target Easily identify stocks' risks and opportunities. Discover stocks' market ...

Wolfe Research upgraded Equinix (NASDAQ:EQIX) to Outperform as its strong balance sheet would offer support in a downturn and the data center REIT is "well-suited for retail inference." ...

Wolfe Research restated their peer perform rating on shares of AZEK (NYSE:AZEK – Free Report) in a research report sent to investors on Wednesday, Marketbeat reports. AZEK has been the topic of ...

Wolfe Research adjusted its price targets and earnings forecasts for Alcoa (NYSE:AA) Corp and Century Aluminum (NASDAQ:CENX) Company, reflecting changes in the alumina market and the impact of tariffs ...

Wolfe Research highlighted key technicals levels for three popular exchange-traded funds: the SPDR S&P 500 ETF Trust (NYSEARCA:SPY), the Invesco QQQ Trust ETF (NASDAQ:QQQ), and the iShares Russell ...

Colossal Biosciences made global headlines when they announced that they had successfully brought the dire wolf back from ...

Management will host investor meetings throughout the day. For further information, please contact your Wolfe Research representative or email [email protected]. About Paymentus Paymentus is a ...